Lysosomes as targets for cancer therapy

Cancer Research

Volumn 65, Issue 8, 2005, Pages 2993-2995

  Fehrenbacher, Nicole ^a   Jäättelä, Marja ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CATHEPSIN INHIBITOR; CYTOTOXIC AGENT; ENZYME INHIBITOR; PROTEINASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER INVASION; CELL COMPOSITION; CELL FUNCTION; CELL IMMORTALIZATION; CELL MEMBRANE PERMEABILITY; CELL TRANSFORMATION; CELL TRANSPORT; CYTOSOL; DISEASE ASSOCIATION; DRUG SENSITIZATION; DRUG TARGETING; ENZYME RELEASE; GENE MUTATION; HUMAN; LYSOSOME; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 17144361820     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0476     Document Type: Review

References (24)

1. deDuve C. Lysosomes revisited. Eur J Biochem 1983;137:391-7.
2. Rawlings ND, Barrett AJ. MEROPS: the peptidase database. Nucleic Acids Res 1999;27:325-31.
3. Reinheckel T, Deussing J, Roth W, Peters C. Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol Chem 2001;382:735-41.
4. Koblinski JE, Ahram M, Sloane BF. Unraveling the role of proteases in cancer. Clin Chim Acta 2000;291:113-35.
5. Jaattela M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 2004;23:2746-56.
6. Kos J, Lah TT. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 1998;5:1349-61.
7. Kane SE, Gottesman MM. The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990;1:127-36.
8. Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci 1994;107:373-84.
9. Joyce JA, Baruch A, Chehade K, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004;5:443-53.
10. Lakka SS, Gondi CS, Yanamandra N, et al. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004;23:4681-9.
11. Guicciardi ME, Leist M, Gores GJ. Lysosomes in cell death. Oncogene 2004;23:2881-90.
12. Cirman T, Oresic K, Mazovec GD, et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004;279:3578-87.
13. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
14. Fehrenbacher N, Gyrd-Hansen M, Poulsen B, et al. Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Cancer Res 2004;64:5301-10.
15. Ciardiello F, Caputo R, Pomatico G, et al. Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A. Int J Cancer 2000;85:710-5.
16. Ono K, Kim SO, Han J. Susceptibility of lysosomes to rupture is a determinant for plasma membrane disruption in tumor necrosis factor α-induced cell death. Mol Cell Biol 2003;23:665-76.
17. Brunk UT, Neuzil J, Eaton JW. Lysosomal involvement in apoptosis. Redox Rep 2001;6:91-7.
18. Mousavi SA, Brech A, Berg T, Kjeken R. Phosphoinositide 3-kinase regulates maturation of lysosomes in rat hepatocytes. Biochem J 2003;372:861-9.
19. Madge LA, Li JH, Choi J, Pober JS. Inhibition of phosphatidylinositol 3-kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis. J Biol Chem 2003;278:21295-306.
20. Nylandsted J, Gyrd-Hansen M, Danielewicz A, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004;200:425-35.
21. Kuopio T, Kankaanranta A, Jalava P, et al. Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res 1998;58:432-6.
22. Liu N, Raja SM, Zazzeroni F, et al. NF-κB protects from the lysosomal pathway of cell death. EMBO J 2003;22:5313-22.
23. Toescu EC. Patching the membranes up-new views on cellular healing. J Cell Mol Med 2003;7:204-5.
24. Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC, Linder S. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 2005;102:192-7.